Peptide
library.
A straightforward reference library for peptides and related compounds: benefits, evidence, practical use, reference dosing and clear context.
Try terms like fat loss, weight loss, recovery, collagen, focus, gut or growth hormone.
Reference ranges shown here are curated educational references, not individualized recommendations. Regulatory status and evidence vary by compound and use.
MOTS-c
Naturally occurring 16-amino-acid mitochondrial-derived peptide studied in metabolic stress, exercise and ageing biology, with no established human therapeutic exposure data.
Reference
5–10 mg
2–3× weekly · 8–12 weeks
GLP-3 Retatrutide
High-interest investigational triple agonist with substantial human trial evidence across obesity and metabolic research.
Reference
0.3–12 mg weekly
Weekly · 12–48 weeks
Tesamorelin
FDA-approved growth-hormone-releasing-factor analogue used to reduce excess abdominal fat in adults with HIV-associated lipodystrophy.
Reference
1–2 mg daily
Daily · 12–16 weeks
Semaglutide
GLP-1 receptor agonist with approved prescription products and extensive randomized human evidence across diabetes, obesity and cardiovascular-risk reduction.
Reference
0.25 mg weekly start; maintenance 0.5–2.4 mg weekly, up to 7.2 mg for certain adults
Once-weekly injection; approved oral formulations are taken once daily